Nosocomial pneumonia control programs: The most difficult questions

T. Pertseva, R. Bontsevich (Dnipropetrovs‘k, Ukraine; Belgorod, Russian Federation)

Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Session: Prognostic indices in respiratory infections
Session type: Thematic Poster Session
Number: 2532
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Objective: To develop and to study nosocomial pneumonia control programs (NPCP) in general surgical departments (GSD).
Significance: We‘ve developed and carried out specific NPCP for GSD and also have studied level of surgeons knowledge and revealed most problem questions.
Study design: Prospective study.
Setting: 6 surgical departments in a city hospital #6.
Study population: Surgeons.
Methods: During 2001-2003 NPCP were developed and carried out among 65 surgeons. There have been considered questions covered control and prophylaxis of nosocomial pneumonia (NP) and other nosocomial infections (NI). Special questionnaire included 27 questions has been created to estimate an initial and final level of medical staff knowledge (LMSK).
Results: After surgeons completed questionnaire at the first time, level of correct answers (LCA) has totaled 48.8%. Taking into account the results of received data there have been developed and carried out special NPCP aimed to increase the LMSK (lectures, discussions, printed issues). Comparative exercise was repeated 1.5 yrs later. Test showed the increase of LCA up to 60 % (p<0.05). We determined that NP-rate was statistically decreasing during NPCP (p<0.05). It was fixed that the most difficult questions were the following: sources of NI agents, risk factors of NI, rationale antibiotic use, hand-hygiene and other NI-preventive measures, mortality rates under NI.
Conclusions: There is a necessity to carry out NPCP among surgeons in GSD to increase LMSK and to decrease NP level. Therefore, the most difficult questions require to be studied more deeply.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pertseva, R. Bontsevich (Dnipropetrovs‘k, Ukraine; Belgorod, Russian Federation). Nosocomial pneumonia control programs: The most difficult questions. Eur Respir J 2012; 40: Suppl. 56, 2532

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nosocomial pneumonia: treatment and prevention
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004


Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019


VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011


Prevention is better than cure: time to change the focus of community-acquired pneumonia management
Source: Eur Respir J 2015; 45: 1524-1525
Year: 2015


Treating nosocomial pneumonia: what's new
Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018
Year: 2018



Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study
Source: International Congress 2019 – Medical education
Year: 2019


Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2011; 39: 7-8
Year: 2012


Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2012; 39: 7-8
Year: 2012


Nosocomial pneumonia in oncology
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Outcomes characteristics in healthcare-associated pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Nosocomial pneumonia: influence of smoking on the course of disease
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Infection control: a priority to stop the nosocomial spread of MDR-/XDR-TB
Source: Annual Congress 2012 - Infection control of respiratory pathogens
Year: 2012


Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Nosocomial pneumonia (non-ventilator-acquired)
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014




Nosocomial pneumonia
Source: CME Online 2010
Year: 2005

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017